Genetics of dilated cardiomyopathy

被引:95
作者
Karkkainen, Satu
Peuhkurinen, Keijo
机构
[1] Kuopio Univ Hosp, Dept Internal Med, Kuopio 70211, Finland
[2] Univ Kuopio, FIN-70211 Kuopio, Finland
基金
英国医学研究理事会;
关键词
cardiomyopathy; dilated; gene;
D O I
10.1080/07853890601145821
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dilated cardiomyopathy (DCM) is a myocardial disease characterized by dilatation and impaired systolic function of the left or both ventricles. The etiology of DCM is multifactorial, and many different clinical conditions can lead to the phenotype of DCM. During recent years it has become evident that genetic factors play an important role in the etiology and pathogenesis of idiopathic DCM. The genetics of DCM have been under intensive investigation lately, and thereby the knowledge on the genetic basis of DCM has increased rapidly. The genetic background of the disease seems to be relatively heterogeneous, and the disease-associated mutations concern mostly single families and only few affected patients. Disease-associated mutations have been detected e.g. in genes encoding sarcomere, cytoskeletal, and nuclear proteins, as well as proteins involved with regulation of Ca2+ metabolism. The mechanisms, by which mutations eventually result in clinical heart failure, are complex and not yet totally resolved. DCM causes considerable morbidity and mortality. Better knowledge of the genetic background and disease-causing mechanisms would probably help us in focusing early treatment on right subjects and potentially also developing new treatment modalities and improving cardiac outcome in the affected patients. This review deals with DCM of genetic origin.
引用
收藏
页码:91 / 107
页数:17
相关论文
共 164 条
[41]   INTEGRAL MEMBRANE-PROTEINS OF THE NUCLEAR-ENVELOPE INTERACT WITH LAMINS AND CHROMOSOMES, AND BINDING IS MODULATED BY MITOTIC PHOSPHORYLATION [J].
FOISNER, R ;
GERACE, L .
CELL, 1993, 73 (07) :1267-1279
[42]   Association of nonsense mutation of dystrophin gene with disruption of sarcoglycan complex in X-linked dilated cardiomyopathy [J].
Franz, WM ;
Müller, M ;
Müller, OJ ;
Herrmann, R ;
Rothmann, T ;
Cremer, M ;
Cohn, RD ;
Voit, T ;
Katus, HA .
LANCET, 2000, 355 (9217) :1781-1785
[43]   Cardiomyopathies:: from genetics to the prospect of treatment [J].
Franz, WM ;
Müller, OJ ;
Katus, HA .
LANCET, 2001, 358 (9293) :1627-1637
[44]   A structural scaffolding of intermediate filaments in health and disease [J].
Fuchs, E ;
Cleveland, DW .
SCIENCE, 1998, 279 (5350) :514-519
[45]   Alcohol abuse and dilated cardiomyopathy in men [J].
Gavazzi, A ;
De Maria, R ;
Parolini, M ;
Porcu, M .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 85 (09) :1114-1118
[46]  
Genschel J, 2000, HUM MUTAT, V16, P451, DOI 10.1002/1098-1004(200012)16:6<451::AID-HUMU1>3.0.CO
[47]  
2-9
[48]   Identification of a novel frameshift mutation in the giant muscle filament titin in a large Australian family with dilated cardiomyopathy [J].
Gerull, B ;
Atherton, J ;
Geupel, A ;
Sasse-Klaassen, S ;
Heuser, A ;
Frenneaux, M ;
McNabb, M ;
Granzier, H ;
Labeit, S ;
Thierfelder, L .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2006, 84 (06) :478-483
[49]  
GERULL B, 2002, NAT GENET, V14, P14
[50]   IDIOPATHIC DILATED CARDIOMYOPATHY [J].
GILLUM, RF .
EPIDEMIOLOGY, 1994, 5 (03) :383-383